» Articles » PMID: 9589644

Circulatory Dysfunction in Asymptomatic in Vitro Fertilization Patients. Relationship with Hyperestrogenemia and Activity of Endogenous Vasodilators

Overview
Specialty Endocrinology
Date 1998 May 20
PMID 9589644
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Severe ovarian hyperstimulation syndrome (OHSS) is consistently associated with a circulatory dysfunction characterized by arterial hypotension, low peripheral vascular resistance, and increased activity of the renin-aldosterone system. To investigate whether circulatory dysfunction also occurs in asymptomatic patients undergoing controlled gonadotropin ovarian hyperstimulation under pituitary suppression for in vitro fertilization (IVF), 12 women without clinical manifestations of OHSS underwent sequential blood, urine, and hemodynamic measurements at five study points: the 7th day of the menstrual cycle preceding IVF (study point 1 or baseline), the day when pituitary suppression was shown (study point 2), the day of hCG ovulatory injection (study point 3), the day after hCG was injected (study point 4), and 7 days after hCG administration (study point 5). Mean arterial pressure, cardiac output, peripheral vascular resistance, plasma concentrations of estradiol (E2) and aldosterone, and plasma renin activity (PRA) were measured at each study point in all women. Serum levels of nitrite/nitrate, and plasma concentration of atrial natriuretic peptide, norepinephrine, adrenomedullin, and cyclic guanosine 3'5'-monophosphate were measured in samples obtained at study points 1 and 5. Multiple follicular development during ovarian stimulation associated with increased plasma E2 concentration (mean peak plasma E2 level, 2430 +/- 428 pg/mL, range 1630-3840 pg/mL) were observed in each woman. All patients developed a significant increase in cardiac output and decrease in arterial pressure and peripheral vascular resistance, and a marked elevation in PRA and aldosterone, all indicating the development of arteriolar vasodilation. Changes in circulatory measurements were temporarily related with the increase in E2 both being detected at study points 3-5. In contrast, there was a clear chronological dissociation between the increase in plasma E2 concentration and the stimulation of the renin-aldosterone system. PRA and aldosterone only reached abnormal levels at study point 5 in association with a significant increase in plasma norepinephrine concentration. Serum levels of nitrite/nitrate and plasma concentrations of atrial natriuretic peptide, adrenomedullin, and cyclic GMP were similar at study points 1 and 5. It is concluded that the circulatory dysfunction that characterizes severe OHSS is a universal event in patients undergoing controlled ovarian hyperstimulation for IVF. Although the increase in E2 levels during IVF cycles is associated with significant circulatory changes, the circulatory dysfunction that characterizes severe OHSS is clearly unrelated to the onset of hyperestrogenemia. Arteriolar vasodilation during IVF cycles was not associated with an increased activity of the vasodilator substances atrial natriuretic peptide, adrenomedullin, and nitric oxide.

Citing Articles

Change of HeART: Cardiovascular Implications of Assisted Reproductive Technology.

Niazi E, Dumanski S CJC Open. 2024; 6(2Part B):142-152.

PMID: 38487072 PMC: 10935705. DOI: 10.1016/j.cjco.2023.09.008.


Assisted reproduction and thromboembolic risk in the COVID-19 pandemic.

Fabregues F, Penarrubia J Reprod Biomed Online. 2020; 41(3):361-364.

PMID: 32660814 PMC: 7316047. DOI: 10.1016/j.rbmo.2020.06.013.


Co action of CFTR and AQP1 increases permeability of peritoneal epithelial cells on estrogen-induced ovarian hyper stimulation syndrome.

Jin P, Lu Y, Li L, Han Q BMC Cell Biol. 2012; 13:23.

PMID: 22928917 PMC: 3443456. DOI: 10.1186/1471-2121-13-23.


The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Grossman L, Michalakis K, Browne H, Payson M, Segars J Fertil Steril. 2009; 94(4):1392-1398.

PMID: 19836016 PMC: 3124341. DOI: 10.1016/j.fertnstert.2009.07.1662.


The cystic fibrosis transmembrane conductance regulator in reproductive health and disease.

Chan H, Ruan Y, He Q, Chen M, Chen H, Ming Xu W J Physiol. 2008; 587(Pt 10):2187-95.

PMID: 19015188 PMC: 2697292. DOI: 10.1113/jphysiol.2008.164970.